Oramed Pharmaceuticals Inc. (ORMP)
Oramed Pharmaceuticals Inc. (ORMP) Insider Trading
Directors, officers and holders of more than 10% of ORMP report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 91 transactions on file: 0 with code P, 4 with code S and 46 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | Gabay Avraham | Chief Financial Officer | S Sale | 20,000 | $4.51 | $90,200 |
| Oct 1, 2026 | Hexter Joshua | COO & CBO | S Sale | 30,000 | $4.51 | $135,330 |
| Sep 24, 2026 | Kidron Miriam | Chief Scientific Officer | D Disposition | 69,999 | Not measured | Not measured |
| Sep 24, 2026 | Kidron Miriam | Chief Scientific Officer | D Disposition | 100,000 | Not measured | Not measured |
| Sep 24, 2026 | Kidron Miriam | Chief Scientific Officer | D Disposition | 104,000 | Not measured | Not measured |
| Sep 24, 2026 | Hexter Joshua | COO & CBO | D Disposition | 36,000 | Not measured | Not measured |
| Sep 24, 2026 | Hexter Joshua | COO & CBO | D Disposition | 50,000 | Not measured | Not measured |
| Sep 24, 2026 | Hexter Joshua | COO & CBO | D Disposition | 50,000 | Not measured | Not measured |
| Sep 24, 2026 | KIDRON NADAV | President and CEO | D Disposition | 107,000 | Not measured | Not measured |
| Sep 24, 2026 | KIDRON NADAV | President and CEO | D Disposition | 150,000 | Not measured | Not measured |
| Sep 24, 2026 | KIDRON NADAV | President and CEO | D Disposition | 97,000 | Not measured | Not measured |
| Sep 24, 2026 | KIDRON NADAV | President and CEO | D Disposition | 49,000 | Not measured | Not measured |
| Sep 24, 2026 | KIDRON NADAV | President and CEO | D Disposition | 190,000 | Not measured | Not measured |
| Sep 24, 2026 | KIDRON NADAV | President and CEO | D Disposition | 196,500 | Not measured | Not measured |
| Sep 24, 2026 | Kidron Miriam | Chief Scientific Officer | D Disposition | 72,000 | Not measured | Not measured |
| Sep 24, 2026 | Kidron Miriam | Chief Scientific Officer | D Disposition | 47,000 | Not measured | Not measured |
| Sep 24, 2026 | Hexter Joshua | COO & CBO | A Award | 75,455 | Not measured | Not measured |
| Sep 24, 2026 | KIDRON NADAV | President and CEO | A Award | 368,765 | Not measured | Not measured |
| Sep 24, 2026 | KIDRON NADAV | President and CEO | A Award | 349,497 | Not measured | Not measured |
| Sep 24, 2026 | Kidron Miriam | Chief Scientific Officer | D Disposition | 100,000 | Not measured | Not measured |
| Sep 24, 2026 | Gabay Avraham | Chief Financial Officer | A Award | 209,291 | Not measured | Not measured |
| Sep 24, 2026 | Kidron Miriam | Chief Scientific Officer | A Award | 209,291 | Not measured | Not measured |
| Sep 24, 2026 | Kidron Miriam | Chief Scientific Officer | A Award | 208,125 | Not measured | Not measured |
| Sep 24, 2026 | Hexter Joshua | COO & CBO | A Award | 209,291 | Not measured | Not measured |
| Jul 2, 2026 | Hexter Joshua | COO & CBO | M Exercise | 50,000 | Not measured | Not measured |
| Jul 2, 2026 | Hexter Joshua | COO & CBO | M Exercise | 50,000 | $3.69 | $184,500 |
| Jul 1, 2026 | Hexter Joshua | COO & CBO | S Sale | 137,000 | $4.46 | $611,431 |
| Jul 1, 2026 | Gabay Avraham | Chief Financial Officer | S Sale | 73,360 | $4.51 | $330,744 |
| Mar 17, 2026 | Kidron Miriam | Chief Scientific Officer | A Award | 119,558 | Not measured | Not measured |
| Mar 17, 2026 | Gabay Avraham | Chief Financial Officer | A Award | 95,889 | Not measured | Not measured |
| Mar 17, 2026 | Hexter Joshua | COO & CBO | A Award | 95,889 | Not measured | Not measured |
| Mar 17, 2026 | KIDRON NADAV | President and CEO | A Award | 167,005 | Not measured | Not measured |
| Mar 12, 2026 | KIDRON NADAV | President and CEO | G Gift | 100,000 | Not measured | Not measured |
| Jan 22, 2026 | Kidron Miriam | Chief Scientific Officer | M Exercise | 19,000 | Not measured | Not measured |
| Jan 22, 2026 | Hexter Joshua | COO & CBO | M Exercise | 19,000 | Not measured | Not measured |
| Jan 22, 2026 | Gabay Avraham | Chief Financial Officer | M Exercise | 19,000 | Not measured | Not measured |
| Jan 22, 2026 | KIDRON NADAV | President and CEO | M Exercise | 109,000 | Not measured | Not measured |
| Jan 22, 2026 | Hexter Joshua | COO & CBO | M Exercise | 19,000 | Not measured | Not measured |
| Jan 22, 2026 | Kidron Miriam | Chief Scientific Officer | M Exercise | 19,000 | Not measured | Not measured |
| Jan 22, 2026 | Gabay Avraham | Chief Financial Officer | M Exercise | 19,000 | Not measured | Not measured |
| Jan 22, 2026 | KIDRON NADAV | President and CEO | M Exercise | 109,000 | Not measured | Not measured |
| Jan 14, 2026 | Kidron Miriam | Chief Scientific Officer | G Gift | 86,166 | Not measured | Not measured |
| Dec 31, 2025 | KIDRON NADAV | President and CEO | A Award | 327,000 | Not measured | Not measured |
| Dec 31, 2025 | Kidron Miriam | Chief Scientific Officer | A Award | 121,331 | Not measured | Not measured |
| Dec 31, 2025 | Kidron Miriam | Chief Scientific Officer | A Award | 115,000 | Not measured | Not measured |
| Dec 31, 2025 | Hexter Joshua | COO & CBO | A Award | 97,328 | Not measured | Not measured |
| Dec 31, 2025 | Gabay Avraham | Chief Financial Officer | A Award | 19,000 | Not measured | Not measured |
| Dec 31, 2025 | Hexter Joshua | COO & CBO | A Award | 115,000 | Not measured | Not measured |
| Dec 31, 2025 | Shapiro Benjamin | Director | A Award | 30,000 | Not measured | Not measured |
| Dec 31, 2025 | Shapiro Benjamin | Director | A Award | 3,500 | Not measured | Not measured |
The full Form 4 history is on the ORMP company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.